Anavex Life Sciences Corp.
- Last sale
- Nov 12, 2026 · -6.37%
- Market cap
- $91.13M
- 92.7M shares
- Filings
- 638
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2014derived
—Q3 2026N/M FY25 yoy
Q3 2026−22.4% FY25 yoy
- $91.13M
- —
- —
- 0.8×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Net Interest Income
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-09-30 | $4,678,000 | reported | |
| FY 2024 | 2024-09-30 | $7,320,000 | reported | |
| FY 2023 | 2023-09-30 | $6,519,000 | reported | |
| FY 2022 | 2022-09-30 | $947,000 | reported | |
| FY 2021 | 2021-09-30 | $26,000 revised | reported | |
| FY 2020 | 2020-09-30 | $179,973 | reported | |
| FY 2019 | 2019-09-30 | $207,280 | reported | |
| FY 2018 | 2018-09-30 | $255,092 | reported | |
| FY 2017 | 2017-09-30 | $88,098 | reported | |
| FY 2016 | 2016-09-30 | $11,322 | reported | |
| FY 2015 | 2015-09-30 | $71,825 | reported | |
| FY 2014 | 2014-09-30 | $7,089 | reported |
Biological products, except diagnostic substances
Anavex Life Sciences Corp. is the 110th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
VYGRVoyager Therapeutics, Inc.$40.4M49.5%296.5%$105.8MCRDLCardiol Therapeutics Inc.———$105.3M
AVXLAnavex Life Sciences Corp. (this company)———$91.1M
TVGNTevogen Inc.———$88.1MBDTXBlack Diamond Therapeutics, Inc.$70.0M—32.0%$86.8MCHRSCoherus Oncology, Inc.$42.2M59.8%398.4%$83.4MNMRANeumora Therapeutics, Inc.———$82.7MATRAAtara Biotherapeutics, Inc.$120.8M6.3%27.1%$80.4MTNYATenaya Therapeutics, Inc.———$79.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR